ArcticZymes Technologies ASA (AZT.OL) Stock Analysis & Winston Score

ArcticZymes Technologies is a Norwegian biotechnology company that makes special proteins called enzymes. These enzymes are harvested from cold-water marine organisms found in the Arctic. The company sells these enzymes to other life science companies, diagnostic labs, and researchers who use them as ingredients to make medical tests, gene therapies, and other biotech products. The company earns money by selling its enzymes as raw materials and research tools, primarily to pharmaceutical and diagnostics manufacturers. It is headquartered in Tromsø, Norway, and operates mainly in European and North American markets. Its competitive edge comes from proprietary cold-active enzymes that perform well at low temperatures, making them useful in sensitive laboratory processes where standard enzymes would not work as well. The main growth driver is rising demand for gene therapy and mRNA-based medicines, which require high-quality enzymes as key ingredients, though the company faces risk from its small scale and dependence on a relatively narrow set of products in a competitive supplier market.